Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experienceYasuhiro Oki, Jason R. Westin, Hun Ju Lee et al.|British Journal of Haematology|2014Cited by 364
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trialNathan Fowler, Sattva S. Neelapu, R. Eric Davis et al.|The Lancet Oncology|2014Cited by 263
The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphomaDai Chihara, Yasuhiro Oki, Michelle A. Fanale et al.|British Journal of Haematology|2016Cited by 118
Antiviral therapy improves overall survival in hepatitis C virus‐infected patients who develop diffuse large B‐cell lymphomaJeff Hosry, Harrys A. Torres, Parag Mahale et al.|International Journal of Cancer|2016Cited by 57
Concomitant use of direct-acting antivirals and chemotherapy in hepatitis C virus-infected patients with cancerMinas P. Economides, Harrys A. Torres, Parag Mahale et al.|Alimentary Pharmacology & Therapeutics|2016Cited by 51